BioSpace Movers & Shakers, Nov. 6
The Pharma Data
NOVEMBER 5, 2020
X4 Pharmaceuticals – Art Taveras was named CSO of Cambridge, Mass.-based Prior to that, Taveras was vice president of Small Molecule Drug Discovery and CMC Development at Biogen Idec, and Alantos Pharmaceuticals, which was acquired by Amgen in 2007. Before GSK, Rosén was senior vice president, U.S. from 1993 to 1995.
Let's personalize your content